- Home
- MAMA vs LXRX Comparison
MAMA vs LXRX Comparison
Compare MAMA & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAMA
- LXRX
- Stock Information
- Founded
- MAMA 2010
- LXRX 1995
- Country
- MAMA United States
- LXRX United States
- Employees
- MAMA N/A
- LXRX N/A
- Industry
- MAMA Specialty Foods
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- MAMA Consumer Staples
- LXRX Health Care
- Exchange
- MAMA Nasdaq
- LXRX Nasdaq
- Market Cap
- MAMA 391.2M
- LXRX 428.8M
- IPO Year
- MAMA N/A
- LXRX 2000
- Fundamental
- Price
- MAMA $9.41
- LXRX $1.15
- Analyst Decision
- MAMA Strong Buy
- LXRX Buy
- Analyst Count
- MAMA 2
- LXRX 5
- Target Price
- MAMA $14.00
- LXRX $3.23
- AVG Volume (30 Days)
- MAMA 306.6K
- LXRX 1.7M
- Earning Date
- MAMA 09-08-2025
- LXRX 11-11-2025
- Dividend Yield
- MAMA N/A
- LXRX N/A
- EPS Growth
- MAMA N/A
- LXRX N/A
- EPS
- MAMA 0.11
- LXRX N/A
- Revenue
- MAMA $135,566,000.00
- LXRX $58,432,000.00
- Revenue This Year
- MAMA $17.24
- LXRX N/A
- Revenue Next Year
- MAMA $9.95
- LXRX N/A
- P/E Ratio
- MAMA $85.48
- LXRX N/A
- Revenue Growth
- MAMA 19.34
- LXRX 1504.83
- 52 Week Low
- MAMA $5.50
- LXRX $0.28
- 52 Week High
- MAMA $9.98
- LXRX $2.18
- Technical
- Relative Strength Index (RSI)
- MAMA 58.52
- LXRX 54.28
- Support Level
- MAMA $8.67
- LXRX $1.03
- Resistance Level
- MAMA $9.95
- LXRX $1.15
- Average True Range (ATR)
- MAMA 0.52
- LXRX 0.06
- MACD
- MAMA 0.10
- LXRX -0.00
- Stochastic Oscillator
- MAMA 73.72
- LXRX 70.59
About MAMA Mama's Creations Inc.
Mama's Creations Inc is a marketer and manufacturer of fresh deli-prepared foods, found in grocery, mass, club, and convenience stores nationally. The company's broad product portfolio, born from a rich history in Italian foods, now consists of a variety of high-quality, fresh, clean, and easy-to-prepare foods to address the needs of both consumers and retailers. The brand of the company includes Mama's Creations, Mama's Mancini's, The Olive Branch, Creative Salads, and others.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.